Ischaemia–reperfusion (I–R) injury, initiated via bursts of reactive oxygen species produced
during the reoxygenation phase following hypoxia, is well known in a variety of acute …

ABSTRAK Pandemi Coronavirus disease 2019 (COVID-19) telah berlangsung sejak Maret
2020 hingga saat ini sudah hampir dua tahun melanda dunia, tak terkecuali Indonesia …

The infection with the SARS-CoV-2 virus is associated with numerous systemic
involvements. Besides the severe respiratory injuries and cardiovascular complications, it …

Background Data on thrombosis and current real-world management strategies for
anticoagulation therapy are scarce but important for understanding current issues and …

Obesity has been recognized as one of the most significant risk factors for the deterioration
and mortality associated with COVID-19, but the significance of obesity itself differs among …

Abstract Background Coronavirus disease 2019 (COVID-19) is frequntly accompanied by
venous thromboembolism (VTE), and its mechanism may be related to the abnormal …

Background Thrombosis is a unique complication of coronavirus disease 2019 (COVID-19).
Although antiphospholipid antibodies (aPL) are detected in COVID-19 patients, their clinical …

The presence of a procoagulant state, COVID-19-related coagulopathy, and an increased
rate of thrombotic events (TEs) is widely known about. However, descriptive studies are …

Severe COVID-19 infections are at high risk of causing thromboembolic events (TEEs).
However, the usual exams may be unavailable or unreliable in predicting the risk of TEEs at …

COVID-19, the infectious disease caused by severe acute respiratory syndrome coronavirus-
2 (SARS-CoV-2), is frequently associated with pulmonary thrombotic events, especially in …